30 November 2017 - Information is available on the Department of Health website setting out the biosimilar brands of medicines which have been approved by the TGA and subsidised on the PBS.
A biosimilar of AbbVie's Humira (adalimumab) was listed on the Australian Register of Therapeutic Goods on 9 November 2017.